Clinical Trial: Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07725575) titled 'Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia' on July 21.

Brief Summary: The goal of this clinical trial is to learn if budesonide works to prevent bronchopulmonary dysplasia in newborn less than 32 weeks gestational age or birth weight less than 1500 g with respiratory distress syndrome who needs surfactants. Does budesonide lower the incidence of bronchopulmonary dysplasia? What medical problems do participants have after given budesonide? Researchers will compare intratracheal budesonide and surfactant to intratracheal surfactant only to see if budesonide works to prevent bronchopumon...